Shares of Proteome Sciences plc (LON:PRM – Get Free Report) traded up 9% during mid-day trading on Monday . The company traded as high as GBX 3.91 ($0.05) and last traded at GBX 3.35 ($0.04). 967,070 shares were traded during mid-day trading, an increase of 496% from the average session volume of 162,146 shares. The stock had previously closed at GBX 3.07 ($0.04).
Proteome Sciences Price Performance
The stock has a market capitalization of £9.65 million, a P/E ratio of -327.00 and a beta of 0.07. The firm’s 50 day moving average price is GBX 2.73 and its 200 day moving average price is GBX 3.15.
About Proteome Sciences
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Read More
- Five stocks we like better than Proteome Sciences
- Why Invest in High-Yield Dividend Stocks?
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- 2 Drone Stocks Surging from Increased Media Attention
- The Role Economic Reports Play in a Successful Investment Strategy
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
